Anti-modified LDL antibodies and LDL-containing immune complexes in IDDM patients and healthy controls

Clinical Immunology and Immunopathology

Volumn 85, Issue 1, 1997, Pages 73-82

  Mironova, Marina ^a   Virella, Gabriel ^a   Virella Lowell, Isabel ^a   Lopes Virella, Maria F ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CHOLESTEROL ESTER; LOW DENSITY LIPOPROTEIN;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; ERYTHROCYTE; FEMALE; FOAM CELL; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MALE; PRIORITY JOURNAL;

EID: 0031259751     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4404     Document Type: Article

References (37)

1. Lopes-Virella M. F., Virella G. Atherosclerosis and autoimmunity. Clin. Immunol. Immunopathol. 73:1994;155-167.
2. Klimov A. N., Denisenko A. D., Vinogradov A. G., Nagornev V. A., Pivovarova Y. I., Sitnikova O. D., Pleskov A. G. Accumulation of cholesteryl esters in macrophages incubated with human lipoprotein-antibody autoimmune complex. Atherosclerosis. 74:1988;41-46.
3. Tertov V., Orekhov A. N., Sayadyan K. S., Serebrennikov S. G., Kacharava A. G., Lyakishev A. A., Smirnov V. N. Correlation between cholesterol content and circulating immune complexes and atherogenic properties of CHD patients' serum manifested in cell culture. Atherosclerosis. 81:1990;183-189.
4. Tertov V. V., Orekhov A. N., Kacharava A. G., Sobenin I. A., Perova N. V., Smirnov V. N. Low density lipoprotein-containing circulating immune complexes and coronary atherosclerosis. Exp. Mol. Pathol. 52:1990;300-308.
5. Schaffner T., Taylor K., Bartucci E. J., Fischer-Dzoga K., Beeson J. H., Glagov S., Wissler R. Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages. Am. J. Pathol. 100:1980;57-80.
6. Gerrity R. G. The role of the monocyte in atherogenesis: Transition of blood monocytes into foam cells in fatty lesions. Am. J. Pathol. 103:1981;181-200.
7. Lopes-Virella M. F., Griffith R. L., Shunk K. A., Virella G. T. Enhanced uptake and impaired intracellular metabolism of low density lipoprotein complexed with anti-low density lipoprotein antibodies. Arterioscler. Thromb. 11:1991;1356-1367.
8. Griffith R. L., Virella G. T., Stevenson H. C., Lopes-Virella M. F. LDL metabolism by macrophages activated with LDL immune complexes: A possible mechanism of foam cell formation. J. Exp. Med. 168:1988;1041-1059.
9. Gissinger C., Virella G. T., Lopes-Virella M. F. Erythrocyte-bound low density lipoprotein (LDL) immune complexes lead to cholesteryl ester accumulation in human monocyte-derived macrophages. Clin. Immunol. Immunopathol. 59:1991;37-51.
10. Gisinger C., Lopes-Virella M. F. Lipoprotein immune complexes and diabetic vascular complications. Diabetes. 41:1992;92-96.
11. Kannel W. B., McGee D. L. Diabetes and cardiovascular disease: The Framingham Study. Diabetes. 241:1979;2035-2038.
12. Wolf S. P., Dean R. T. Glucose autoxidation and protein modification: The potential role of "autoxidative glycation" in diabetes mellitus. Biochem. J. 245:1987;243-250.
13. Reaven P. D., Picard S., Witzum J. L. LDL metabolism in diabetes. Diabetes and Atherosclerosis. 1993;Elsevier, Amsterdam. p. 17-38.
14. Virella G., Virella I., Leman R. B., Pryor M. B., Lopes-Virella M. F. Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers. Int. J. Clin. Lab. Res. 23:1993;95-101.
15. Haberland M. E., Fless G. M., Scanu A. M., Fogelman A. M. Malondialdehyde modification of lipoprotein (a) produces avid uptake by human monocyte-macrophages. J. Biol. Chem. 267:1992;4143-4151.
16. Lopes-Virella M. F., Klein R. L., Lyons T. J., Stevenson H. C., Witztum J. L. In vitro glucosylated LDL enhances cholesteryl ester synthesis and accumulation in human monocyte-derived macrophages. Diabetes. 37:1988;550-557.
17. Virella G., Shuler C. W., Sherwood T. Noncomplement-dependent adsorbtion of soluble immune complexes to human red blood cells. Clin. Exp. Immunol. 54:1983;448-454.
18. Sherwood T. A., Virella G. The binding of immune complexes to human red cells: Complement requirements and fate of the RBC-bound IC after interaction with human phagocytic cells. Clin. Exp. Immunol. 64:1986;195-204.
19. Fogelman A. M., Elahi F., Sykes K., Van Lenten B. J., Territo M., Berliner J. Modification of the Recalde method for the isolation of human monocytes. J. Lipid Res. 29:1988;1243-1247.
20. Recalde H. R. A simple method of obtaining monocytes in suspension. J. Immunol. Methods. 69:1984;71-77.
21. Hara A., Radin N. S. Lipid extraction of tissues with a low toxicity solvent. Anal. Biochem. 90:1978;420-426.
22. Ishikawa T. T., MacGee J., Morrison J. A., Glueck C. J. Quantitative analisis of cholesterol in 5 to 50 μl of plasma. J. Lipid Res. 15:1974;286-291.
23. Lopes-Virella M. F., Sherer G. K., Lees A. M., Wohltmann H., Mayfield R., Sagel J., Leroy C., Colwell J. A. Surface binding, internalization and degradation by cultured human fibroblasts of LDL isolated from type I (insulin-dependent) diabetic patients: Changes with metabolic control. Diabetologia. 22:1982;430-436.
24. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
25. Hollander W., Colombo M. A., Kirkpatrick B., Paddock J. Soluble proteins in the human atherosclerotic plaque. Atherosclerosis. 34:1979;391-405.
26. Seifert P. S., Hansson G. K. Complement receptors and regulatory proteins in human atherosclerotic lesions. Arteriosclerosis. 9:1989;802-811.
27. Orekhov A. N., Tertov V. V., Kabakov A. E., Adamova I. Y., Pokrovsky S. N., Smirnov V. N. Autoantibodies against modified low density lipoprotein: Nonlipid factor of blood plasma that stimulates foam cell formation. Arterioscler. Thromb. 11:1991;316-326.
28. Salonen J. T., Yla-Herttuala S., Yamamoto R., Butler S., Korpela H., Salonen R., Nyyssönen R., Palisnki W., Witzum J. L. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet. 339:1992;883-887.
29. Virella G., Munoz J. F., Galbraith G. M. P., Gissinger C., Chassereau C., Lopes-Virella M. F. Activation of human monocyte-derived macrophages by immune complexes containing low density lipoprotein. Clin. Immunol. Immunopathol. 75:1995;179-189.
30. Witzum J. L., Steinbrecher U. P., Kesaniemi Y. A., Fisher M. Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus. Proc. Natl. Acad. Sci. USA. 81:1984;3204-3208.
31. Bellomo G., Maggi E., Poli M., Agosta F. G., Bolatti P., Finardi G. Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM. Diabetes. 44:1995;60-66.
32. Mironova M., Lopes-Virella M. F., Virella G. Isolation and characterization of human anti-oxidized LDL auto-antibodies. Arterioscler. Thromb. Vasc. Biol. 16:1996;222-229.
33. Triolo G., Giadina E., Zarcone M. R., Giordano C., Rinaldi A., Bompiani G. D. Contribution of secretory IgA, polymeric IgA and IgA/secretory component-containing circulating immune complexes to the serum hyper-IgA in diabetes mellitus. Diabetologia. 27:1984;157-159.
34. Ohmuro H., Tomino Y., Tsushima Y., Shimizu M., Kuramoto T., Koide H. Elevation of serum IgA levels in patients with diabetic nephropathy. Nephron. 63:1993;335.
35. Koschinsky T., Bunting C. E., Glahn U., Butler S., Palinski W., Witztum J. L. Increased titer of immunoglobulin A antibody to oxidized LDL in diabetic patients. Diabetes. 41:1992;4A.
36. Monteiro R. C., Kubagawa H., Cooper M. D. Cellular distribution, regulation, and biochemical nature of an Fcα receptor in humans. J. Exp. Med. 171:1990;597-613.
37. Nikolova E. B., Russell M. W. Dual function of human IgA antibodies: Inhibition of phagocytosis in circulating neutrophils and enhancement of responses in IL-8 stimulated cells. J. Leukocyte Biol. 57:1995;875-882.